MARKET

ZVRA

ZVRA

Zevra Therapeutics Inc
NASDAQ
7.92
+0.17
+2.19%
Opening 15:05 05/13 EDT
OPEN
7.83
PREV CLOSE
7.75
HIGH
7.93
LOW
7.64
VOLUME
333.78K
TURNOVER
0
52 WEEK HIGH
9.76
52 WEEK LOW
4.200
MARKET CAP
433.06M
P/E (TTM)
-3.4717
1D
5D
1M
3M
1Y
5Y
1D
Zevra Therapeutics, Inc. Q1 2025 Earnings Preview
Seeking Alpha · 21h ago
Zevra Therapeutics's Earnings Outlook
Benzinga · 23h ago
Weekly Report: what happened at ZVRA last week (0505-0509)?
Weekly Report · 1d ago
Xeris Biopharma (XERS) Reports Q1 Loss, Tops Revenue Estimates
NASDAQ · 5d ago
Zevra Therapeutics Announces Details for Q1 2025 Financial Results Call
Barchart · 05/06 06:30
Weekly Report: what happened at ZVRA last week (0428-0502)?
Weekly Report · 05/05 09:15
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Could Be Less Than A Year Away From Profitability
Simply Wall St · 05/03 13:15
Zevra Therapeutics (ZVRA) Receives a Buy from Cantor Fitzgerald
TipRanks · 05/01 12:29
More
About ZVRA
More
Zevra Therapeutics, Inc. is a rare disease company science, data, and patients need to create transformational therapies for diseases with limited or no treatment options. The Company has a diverse portfolio of products and product candidates, which includes a combination of both a clinical stage pipeline and commercial stage assets. Its pipeline includes arimoclomol, an orally delivered, investigational product candidate being developed for Niemann-Pick disease type C (NPC). KP1077 is the Company's lead clinical development product candidate which is being developed as a treatment for idiopathic hypersomnia (IH), a rare neurological sleep disorder, and narcolepsy. Its commercial product, AZSTARYS, a once-daily treatment for attention deficit hyperactivity disorder (ADHD), in patients aged six years and older containing its prodrug, serdexmethylphenidate (SDX), and d-methylphenidate (d-MPH). Its other commercial product is OLPRUVA.
Recently
Symbol
Price
%Change

Webull offers Zevra Therapeutics Inc stock information, including NASDAQ: ZVRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZVRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ZVRA stock methods without spending real money on the virtual paper trading platform.